Loading
The Neuroscience Chronicles
ISSN: 2767-3405
2020
Volume 1, Issue 1, p1-17
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
Role of Ginseng in therapeutic management of Alzheimer’s Disease
Rudrarup Bhattacharjee, Amarendranath Choudhury
While much of research progress has been achieved in last century on Alzheimer’s Disease (AD), the conclusive therapy for the same is still unachieved. Several lines of therapeutic regimes have been introduced, which basically act on slowing down the disease progression.
Neurosci Chron, 2020, Volume 1, Issue 1, p1-3 | DOI: 10.46439/Neuroscience.1.001
Association of COVID-19 coronavirus and Kawasaki syndrome like features in 1-5 years old children
Bittmann S, Weissenstein A, Villalon G, Elena Moschüring-Alieva, Luchter E
In the nightmare of the coronavirus pandemic that is spreading around the world, parents could take comfort in one thing - early reports that the virus mysteriously spares children, even though this often leads to critical illness in older people. An article published in the Journal “Pediatrics”, based on 2,143 young people in China, provides the most comprehensive evidence of the spread of the virus among children, and there is bad news and good news [1].
Neurosci Chron, 2020, Volume 1, Issue 1, p4-5 | DOI: 10.46439/Neuroscience.1.002
Parkinson’s disease: cell therapy vs. gene therapy
Ashok Chakraborty, Anil Diwan
Parkinson’s disease (PD) is the second most common neurodegenerative disease, manifesting as a characteristic movement disorder with a number of additional non-motor features. The pathological hallmark of PD is the presence of intra-neuronal aggregates of a-synuclein (Lewy bodies). The movement disorder of PD occurs largely due to loss of dopaminergic neurons of the substantia nigra, resulting in striatal dopamine depletion.
Neurosci Chron, 2020, Volume 1, Issue 1, p6-10 | DOI: 10.46439/Neuroscience.1.003
MicroRNA silencing: A promising therapy for Alzheimer’s disease
Neelima B. Chauhan
Alzheimer’s disease (AD) is a global health crisis currently afflicting ~6 million Americans (and ~40 million people worldwide). By the middle of the century, these numbers will stagger by ~16 million Americans (and ~152 million people worldwide) suffering from AD, if breakthrough disease-modifying treatments are not discovered.
Neurosci Chron, 2020, Volume 1, Issue 1, p11-15 | DOI: 10.46439/Neuroscience.1.004
Overcrowding modulates the response of adolescents to psychoactive drugs
Michael K. Ibrahim, Fatma M. Sabry, M. Raouf Hamed
Overcrowding is a growing problem that prevails in the urban areas of both developing and developed countries. It is considered as psycho-social stress that affects the behavior and physiology of individuals and societies [1].
Scientific awareness of overcrowding stress systematically started in the 1960s with the early experiments of John B. Calhoun using the so-called “rat utopia” and the theory of “behavioral sink” [2]. Depending on Calhoun’s experiments, connections between the model of rodent colonies and the arising problems of crowded cities were extrapolated [3].
